About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Shutting Nrf1 can Reduce Resistance to Blood Cancer Drugs

by Anjali Aryamvally on October 26, 2017 at 3:44 PM
Font : A-A+

Shutting Nrf1 can Reduce Resistance to Blood Cancer Drugs

Proteasome inhibitors, a new class of drugs for blood cancers such as leukemia and multiple myeloma is showing promise. But just like other cancer drugs, targeted cells can develop resistance which reduces the efficacy of the drugs. A study published in ACS Central Science, have found how resistance works by studying a rare genetic disease known as NGLY1 deficiency.

Advertisement


A class of compounds called proteasome inhibitors that include bortezomib and carfilzomib -- both approved by the U.S. Food and Drug Administration -- have been effective at treating certain types of blood cancers. The drugs work by jamming some of cancer cells' machinery to induce cell death. But the drugs have been limited by cancer cells ability to develop resistance, as well as the inhibitors inability to fight solid tumors effectively. Studies have suggested that resistance could be linked to a protein called Nrf1. When proteasome inhibitors go into action, Nrf1 is spurred into overdrive to restore the cells' normal activities and keep them alive. If researchers could figure out how to block Nrf1, they might be able to address the resistance problem. Carolyn Bertozzi and colleagues, through studying NGLY1 deficiency, a seemingly unrelated condition, may have hit upon an approach to do this.

The researchers were investigating how lacking the enzyme NGLY1 causes a host of debilitating symptoms. They found that NGLY1 is responsible for activating Nrf1, the protein that is suspected of weakening proteasome inhibitors' effectiveness against cancer. Further testing showed that dampening NGLY1 allowed a proteasome inhibitor to continue doing its work killing cancer cells without interference from Nrf1. This finding, the authors note, holds great promise for the development of combination therapeutics for blood cancers in the future.



Source: Eurekalert
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Advertisement
News Category
What's New on Medindia
Top 7 Benefits of Good Oral Hygiene
Healthy and Safer Thanksgiving 2021
Long-Term Glycemic Control - A Better Measure of COVID-19 Severity
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Drug Toxicity Thalassemia Cancer and Homeopathy Cancer Facts Cancer Tattoos A Body Art Drugs Banned in India Hairy Cell Leukemia Blood in Stools - Symptom Evaluation Bombay Blood Group 

Recommended Reading
Multiple Myeloma Linked to Defective 'protein Factory'
Defects in the ribosome of multiple myeloma patients have been discovered by researchers....
Newly Identified Molecular Mechanisms Help to Prevent Autoimmune Diseases
Scientists discover molecular mechanisms to selectively inhibit human immunoproteasome to prevent .....
Identifying the Key Elements of Cellular Response to Proteasome Dysfunction
Key molecules in the pathway by which cells in the C. elegans sense proteasome dysfunction ha...
John Theurer Cancer Center Leads from the Front in Proteasome Inhibitor Carfilzomib Studies
Three separate multicenter studies were conducted by researchers at John Theurer Cancer Center at .....
Blood in Stools - Symptom Evaluation
Blood in stools results from bleeding that arises from any part of the digestive tract. Causes of bl...
Bombay Blood Group
Bombay blood group is a rare blood type in which the people have an H antigen deficiency. They can r...
Drug Toxicity
Drug toxicity is an adverse reaction of the body towards a drug that results as a side effect of a d...
Drugs Banned in India
Several drugs are either banned or withdrawn after introduction in the market....
Hairy Cell Leukemia
Hairy cell leukemia (HCL) is a type of leukemia where there are increased numbers of abnormal B-lymp...
Tattoos A Body Art
Tattoos are a rage among college students who sport it for the ‘cool dude’ or ‘cool babe’ look...
Thalassemia
Thalassemia is an inherited blood disorder passed on through parental genes causing the body to prod...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use